ReFERENCES

  1. Centers for Disease Control and Prevention. Pre-exposure prophylaxis for the prevention of HIV infection in the United States—2014: a clinical practice guideline, 2014. Accessed January, 4 2017.
  2. Grohskopf LA, Chillag KL, Gvetadze R, et al. Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States. J Acquired Immune Defic Syndr. 2013;64(1):79-86.
  3. The Colorado HIV/AIDS Strategy 2017-2021, Table 3.18, page 45; Table 3.21, page 49; Table 4.22, page 75.
  4. Second Man Contracts Rare HIV Strain While Adhering to PrEP. October 19, 2016. Accessed 30 November 2016.
  5. PrEP Fails in a Third Man, But This Time HIV Drug Resistance Is Not to Blame, February 16, 2017. Accessed February 17, 2017.
  6. Centers for Disease Control and Prevention. Volume 21, Number 4: Monitoring Selected National HIV Prevention and Care Objectives by Using HIV Surveillance Data United States and 6 Dependent Areas, 2014.
  7. Estimated Percentages and Numbers of Adults with Indications for Pre-exposure Prophylaxis (PrEP), by Transmission Risk Group — United States, 2015 (Smith et.al – Presented at 2015 National HIV Prevention Conference).
  8. Centers for Disease Control and Prevention. HIV Surveillance Report, 2015; vol. 27. Published November 2016. Accessed March 3, 2017.
  9. S Bush, D Magnuson, M Rawlings, et al. Racial Characteristics of FTC/TDF for Pre-Exposure Prophylaxis Users in the US. ASM Microbe. June 16-20, 2016. Abstract 2651.
  10. American Men’s Internet Survey (AMIS): Online HIV Behavioral Survey of Men Who Have Sex with Men, Denver, 2014.
  11. Anderson, Peter L., et al. "Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men." Science Translational Medicine 4.151 (2012): 151ra125-151ra125.
  12. Smith, Dawn K., et al. "Antiretroviral post-exposure prophylaxis after sexual, injection-drug use, or other non-occupational exposure to HIV in the United States: recommendations from the US Department of Health and Human Services." MMWR Recomm Rep 54.RR-2 (2005): 1-20.
  13. Grant RM, Lama JR, Anderson PL, et al. Pre-exposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587-2599.
  14. Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399-410.
  15. "U.S. PrEP Users Likely Exceeded 80,000 by End of 2015." July 21, 2016. Accessed January 10, 2017.
  16. "Melbourne man tests positive to HIV while taking preventative drug." May 22, 2017.